Medtronic Confirms $42.9B Covidien Inversion On Track
Medtronic Inc. said Tuesday it still plans to complete its $42.9 billion merger with Covidien PLC early next year, solidifying prospects for the largest inversion still on the table after the...To view the full article, register now.
Already a subscriber? Click here to view full article